Optimal sample size allocation and go/no-go decision rules for phase II/III programs where several phase III trials are performed (Q4967100)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Optimal sample size allocation and go/no-go decision rules for phase II/III programs where several phase III trials are performed |
scientific article; zbMATH DE number 7075689
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Optimal sample size allocation and go/no-go decision rules for phase II/III programs where several phase III trials are performed |
scientific article; zbMATH DE number 7075689 |
Statements
Optimal sample size allocation and go/no‐go decision rules for phase II/III programs where several phase III trials are performed (English)
0 references
2 July 2019
0 references
drug development program
0 references
optimization
0 references
phase II/III
0 references
probability of success
0 references
sample size
0 references
0.7725093364715576
0 references
0.7438843250274658
0 references
0.742613673210144
0 references
0.725401759147644
0 references
0.7212077975273132
0 references
